{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": -1.7055597, "regularMarketPrice": 2.19, "earningsTimestamp": 1684236600, "earningsTimestampStart": 1684236600, "earningsTimestampEnd": 1684236600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.157, "sharesOutstanding": 203063008, "bookValue": 1.578, "fiftyDayAverage": 4.174276, "fiftyDayAverageChange": -1.9842758, "fiftyDayAverageChangePercent": -0.4753581, "twoHundredDayAverage": 5.3517137, "twoHundredDayAverageChange": -3.1617136, "twoHundredDayAverageChangePercent": -0.59078526, "marketCap": 6015645, "priceToBook": 1.3878328, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1517212800000, "priceHint": 4, "marketState": "POSTPOST", "exchange": "LSE", "shortName": "PALATIN TECHNOLOGIES INC PALATI", "longName": "Palatin Technologies, Inc.", "messageBoardId": "finmb_32651", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": -0.03799987, "regularMarketTime": 1683898545, "regularMarketDayHigh": 2.19, "regularMarketDayRange": "2.19 - 2.19", "regularMarketDayLow": 2.19, "regularMarketVolume": 20, "regularMarketPreviousClose": 2.228, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 2.19, "averageDailyVolume3Month": 386, "averageDailyVolume10Day": 365, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "2.19 - 9.1075", "fiftyTwoWeekHighChange": -6.9175, "fiftyTwoWeekHighChangePercent": -0.7595388, "fiftyTwoWeekLow": 2.19, "fiftyTwoWeekHigh": 9.1075, "symbol": "0KF3.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Cedar Brook Corporate Center", "address2": "4-B Cedar Brook Drive", "city": "Cranbury", "state": "NJ", "zip": "08512", "country": "United States", "phone": "609 495 2200", "fax": "609 495 2202", "website": "https://palatin.com", "industry": "", "sector": "", "longBusinessSummary": "Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl  Spana Ph.D.", "age": 60, "title": "Co-Founder, Pres, CEO & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 943250, "fmt": "943.25k", "longFmt": "943,250"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen T. Wills CPA, CPA, MST", "age": 65, "title": "CFO, COO, Exec. VP, Treasurer & Sec.", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 870574, "fmt": "870.57k", "longFmt": "870,574"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Burns  McClellan", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen A. Slusher Esq.", "title": "Chief Legal Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael B. Raizman M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James E. Hattersley", "age": 62, "title": "Sr. VP of Bus. Devel.", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Dodd Ph.D.", "title": "Sr. VP of Preclinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Jordan", "title": "Sr. VP of Program Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}